Last Update18 Sep 25Fair value Decreased 2.71%
The reduction in thyssenkrupp nucera KGaA’s consensus revenue growth outlook has outweighed the minor improvement in net profit margin, resulting in a lowered analyst price target from €11.93 to €11.61.
What's in the News
- Progressive Green Solutions selected thyssenkrupp nucera as preferred supplier of 1.4 GW electrolyzers for its Western Australia Mid-West Green Iron project, marking a significant green hydrogen technology deployment.
- Fiscal 2024/2025 guidance confirmed: consolidated sales expected at EUR 850–920 million, green hydrogen segment sales at EUR 450–510 million, CA segment sales at EUR 380–420 million, with consolidated EBIT guided to loss EUR 7 million to EUR 7 million.
- TGV SRAAC Ltd. commissioned thyssenkrupp nucera to expand its chlor-alkali plant capacity in Andhra Pradesh, India by 50% to 1,500 tonnes per day, using latest eBiTAC v7 technology.
- CMDC (part of BCI) contracted thyssenkrupp nucera for chlor-alkali plant expansion in Jubail, Saudi Arabia, involving EUR 15 million supply of advanced energy-efficient membrane technology.
- Q3 2024/2025 sales expected at EUR 184 million (down from prior year’s EUR 237 million), with EBIT at EUR 0 million.
Valuation Changes
Summary of Valuation Changes for thyssenkrupp nucera KGaA
- The Consensus Analyst Price Target has fallen slightly from €11.93 to €11.61.
- The Consensus Revenue Growth forecasts for thyssenkrupp nucera KGaA has significantly fallen from -0.5% per annum to -1.7% per annum.
- The Net Profit Margin for thyssenkrupp nucera KGaA has risen slightly from 4.28% to 4.42%.
Key Takeaways
- Positioned to benefit from rising global green hydrogen demand, with policy support and growing engineering contracts pointing to strengthened long-term growth and order visibility.
- Service expansion, strategic acquisitions, and advanced R&D support higher-margin revenues, improved earnings quality, and greater competitiveness in core and emerging markets.
- Revenue and earnings are at risk due to project delays, weak order intake, high reliance on a few large contracts, and ongoing innovation pressures.
Catalysts
About thyssenkrupp nucera KGaA- Engages in the development, engineering, procurement, commissioning, and licensing of high-performance electrolysis technologies in Germany, Italy, the Middle East, Africa, South America, Asia, and internationally.
- Recent project delays and smaller average project size have weighed on near-term revenues, but thyssenkrupp nucera sits at the center of a major long-term shift as global decarbonization policies and corporate net-zero mandates support the structural ramp-up in green hydrogen demand, likely driving a reacceleration in order intake and revenue growth as regulatory certainty and infrastructure buildout progresses.
- The increasing volume of paid FEED (Front-End Engineering Design) and engineering contracts-especially in Europe, which remains the most active region for green hydrogen-signals forthcoming conversion into firm, large-scale orders within 6-12 months, offering improved medium-term revenue visibility.
- Expansion of the service and aftermarket business in the chlor-alkali segment (with rising orders from the Middle East, Central Europe, U.S., and China) is boosting recurring, higher-margin revenues-evidenced by the stable or growing EBIT in this segment-supporting gross margin expansion and enhanced earnings quality over time.
- Strategic technology acquisitions (such as Green Hydrogen Systems) and accelerated R&D, including SOEC pilot plant launches, are enabling thyssenkrupp nucera to lower the levelized cost of hydrogen, strengthen its technological edge, and address a broader spectrum of industrial decarbonization use cases, improving the company's long-term competitiveness and margin potential.
- U.S. policy support for green hydrogen, driven by recent clarity on funding eligibility and tax incentives, is creating renewed momentum in a key growth market; strong positioning on advanced projects there and in the Middle East means the company is poised to benefit from increased order activity and improved revenue trajectory once permitting and FID hurdles resolve.
thyssenkrupp nucera KGaA Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming thyssenkrupp nucera KGaA's revenue will decrease by 0.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 1.7% today to 4.3% in 3 years time.
- Analysts expect earnings to reach €38.7 million (and earnings per share of €0.32) by about September 2028, up from €16.0 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €17.9 million.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 45.9x on those 2028 earnings, down from 71.7x today. This future PE is greater than the current PE for the DE Construction industry at 27.9x.
- Analysts expect the number of shares outstanding to decline by 0.25% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.04%, as per the Simply Wall St company report.
thyssenkrupp nucera KGaA Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Delays and cancellations in large-scale green hydrogen projects, especially due to offtake risks, lack of infrastructure, and regulatory uncertainty, have led to a downsized and less valuable project pipeline, which could result in lower revenue growth and reduced order intake over the coming years.
- Order intake in the green hydrogen segment has been soft, with project postponements and client reluctance to make final investment decisions, raising the risk of a slowdown in sales and order backlog impacting future top-line growth.
- Workload in green hydrogen is currently declining, and the company expects a phase of sales slowdown next year due to lagging order intake this year-potentially leading to lower revenue and underutilization of fixed costs, which may pressure net margins and earnings.
- Persistent competitive and technological pressures require continued investment in R&D and new product development (such as scaling up SOEC and pressurized AWE), but high capital intensity and the need for recurring innovation could weigh on operating efficiency and long-term margins if operating leverage is not achieved.
- The company's near
- and mid-term sales outlook is heavily reliant on successfully converting paid engineering contracts and final investment decisions (FIDs) on a handful of large projects, introducing significant concentration risk that could translate into material revenue and earnings volatility if these projects face further delays or cancellations.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of €11.933 for thyssenkrupp nucera KGaA based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €16.0, and the most bearish reporting a price target of just €8.9.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €903.7 million, earnings will come to €38.7 million, and it would be trading on a PE ratio of 45.9x, assuming you use a discount rate of 6.0%.
- Given the current share price of €9.08, the analyst price target of €11.93 is 23.9% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.